NCT03224091 PROspective Longitudinal All-comer Inclusion Study in Eating Disorders
| NCT ID | NCT03224091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-01-25 |
| Primary Completion | 2030-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-01-25 with a primary completion date of 2030-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PROLED study is a prospective and longitudinal study of patients with Eating Disorders. Annual interviews and collection of biological samples are done, as well as during changes in disease course e.g. during hospitalization. Included are qualitative interviews, psychometric tests, questionnaires which are used to collect data on psychopathology. There is also collection of blood, urine and faeces.
Eligibility Criteria
Inclusion Criteria: * Eating Disorder (ICD-10) Exclusion Criteria: * Forced care/non-voluntary
Contact & Investigator
Louise Behrend_Rasmussen, MD,PhD
STUDY CHAIR
Mental Health Center Ballerup
Frequently Asked Questions
Who can join the NCT03224091 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03224091 currently recruiting?
Yes, NCT03224091 is actively recruiting participants. Contact the research team at jan.magnus.sjoegren@regionh.dk for enrollment information.
Where is the NCT03224091 trial being conducted?
This trial is being conducted at Ballerup Municipality, Denmark.
Who is sponsoring the NCT03224091 clinical trial?
NCT03224091 is sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital. The principal investigator is Louise Behrend_Rasmussen, MD,PhD at Mental Health Center Ballerup. The trial plans to enroll 1,000 participants.